A study of the efficacy and tolerability of capecitabine and lobaplatin in advanced HER-2 negative breast cancer patients

BACKGROUND: This study sought to examine the efficacy and adverse reactions of capecitabine and lobaplatin in the treatment of metastatic human epidermal growth factor receptor 2 (HER-2) negative breast cancer (BC). METHODS: This retrospective study examined 45 patients diagnosed with advanced HER-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yuan, Zhang, Lili, Zhang, Zhe, Qian, Yu, Teng, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350665/
https://www.ncbi.nlm.nih.gov/pubmed/34430592
http://dx.doi.org/10.21037/atm-21-2702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350665/
https://www.ncbi.nlm.nih.gov/pubmed/34430592
http://dx.doi.org/10.21037/atm-21-2702

Ejemplares similares